Drug recall
Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle…
FDA recall event 91142 · Class III · Lannett Company Inc.
Key facts
| Event ID | 91142 |
|---|---|
| Recall numbers | D-0160-2023, D-0161-2023 |
| Recalling firm | Lannett Company Inc. |
| Product type | Drugs |
| Products | Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 0527-1632-10, Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Failed Impurity/Degradation Specifications |
| Initiation date | Nov 9, 2022 |
| Report date | Jan 25, 2023 |
| Termination date | Jun 8, 2023 |
| City | Seymour |
| State | IN |
| Country | United States |
| FEI number | 1819171 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: